WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006085328) METHOD AND KIT FOR DIAGNOSING AND PREDICTING HEPATITIS C VIRUS-RELATED NEOPLASTIC TRANSFORMATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/085328    International Application No.:    PCT/IL2006/000185
Publication Date: 17.08.2006 International Filing Date: 13.02.2006
IPC:
C12Q 1/70 (2006.01), C07H 21/04 (2006.01)
Applicants: KLEIN, Ami [IL/IL]; (IL) (For US Only).
MOR RESEARCH APPLICATIONS LTD. [IL/IL]; 20 Ha'magshimim St., Kiryat Matalon, P.O.B. 7590, 49170 Petach Tikva (IL) (For All Designated States Except US)
Inventors: KLEIN, Ami; (IL)
Agent: PYERNIK RUTMAN; Beit Etzion, 91 Herzl St., P.O.Box 10012, 84106 Beer-Sheva (IL)
Priority Data:
60/651,966 14.02.2005 US
Title (EN) METHOD AND KIT FOR DIAGNOSING AND PREDICTING HEPATITIS C VIRUS-RELATED NEOPLASTIC TRANSFORMATION
(FR) METHODE ET TROUSSE PERMETTANT DE DIAGNOSTIQUER ET DE PREVOIR DES TRANSFORMATIONS NEOPLASIQUES LIEES AU VIRUS DE L'HEPATITE C
Abstract: front page image
(EN)The present invention relates to a method for predicting and/or diagnosing neoplastic transformation in a patient infected with HCV, wherein said method comprises the determination of the presence or absence of integration of HCV into the genome of host cells taken from said patient, and wherein the presence of HCV integration is used to identify the patient as being at high risk for developing or already having developed and HCV-related neoplastic condition.
(FR)L'invention porte sur une méthode permettant de prévoir et de diagnostiquer des transformations néoplasiques chez un patient infecté par le VHC, consistant à déterminer la présence ou l'absence d'intégration du VHC dans le génome de cellules hôtes prélevées sur le patient, la présence de cette intégration permettant d'identifier le patient comme présentant un fort risque de développer ou d'avoir déjà développé un état néoplasique lié au VHC.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)